nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CNR2—hematologic cancer	0.418	1	CbGaD
Rimonabant—CYP1A2—Anagrelide—hematologic cancer	0.0255	0.0664	CbGbCtD
Rimonabant—CYP2C9—Bexarotene—hematologic cancer	0.0159	0.0415	CbGbCtD
Rimonabant—CYP2D6—Lomustine—hematologic cancer	0.0135	0.0353	CbGbCtD
Rimonabant—CYP1A2—Carmustine—hematologic cancer	0.0134	0.0349	CbGbCtD
Rimonabant—CYP2C9—Idarubicin—hematologic cancer	0.0132	0.0344	CbGbCtD
Rimonabant—CYP2D6—Idarubicin—hematologic cancer	0.012	0.0314	CbGbCtD
Rimonabant—CYP1A2—Methoxsalen—hematologic cancer	0.0114	0.0297	CbGbCtD
Rimonabant—CYP1A2—Bortezomib—hematologic cancer	0.0108	0.0282	CbGbCtD
Rimonabant—CYP1A2—Daunorubicin—hematologic cancer	0.0103	0.027	CbGbCtD
Rimonabant—CYP2D6—Hydroxyurea—hematologic cancer	0.0102	0.0267	CbGbCtD
Rimonabant—CYP1A2—Alitretinoin—hematologic cancer	0.0101	0.0264	CbGbCtD
Rimonabant—CYP2C9—Bortezomib—hematologic cancer	0.00974	0.0254	CbGbCtD
Rimonabant—CYP1A2—Thalidomide—hematologic cancer	0.00942	0.0246	CbGbCtD
Rimonabant—CYP3A4—Bexarotene—hematologic cancer	0.00924	0.0241	CbGbCtD
Rimonabant—CYP2D6—Bortezomib—hematologic cancer	0.00891	0.0232	CbGbCtD
Rimonabant—CYP3A4—Lomustine—hematologic cancer	0.00859	0.0224	CbGbCtD
Rimonabant—CYP3A4—Busulfan—hematologic cancer	0.00859	0.0224	CbGbCtD
Rimonabant—CYP2C9—Thalidomide—hematologic cancer	0.00849	0.0221	CbGbCtD
Rimonabant—CYP1A2—Dacarbazine—hematologic cancer	0.0081	0.0211	CbGbCtD
Rimonabant—CYP2C9—Teniposide—hematologic cancer	0.0081	0.0211	CbGbCtD
Rimonabant—CYP1A2—Imatinib—hematologic cancer	0.00792	0.0207	CbGbCtD
Rimonabant—CYP3A4—Thiotepa—hematologic cancer	0.00766	0.02	CbGbCtD
Rimonabant—CYP2C9—Ifosfamide—hematologic cancer	0.00747	0.0195	CbGbCtD
Rimonabant—CYP2C9—Imatinib—hematologic cancer	0.00714	0.0186	CbGbCtD
Rimonabant—CYP2D6—Imatinib—hematologic cancer	0.00653	0.017	CbGbCtD
Rimonabant—CYP2C9—Nilotinib—hematologic cancer	0.00649	0.0169	CbGbCtD
Rimonabant—CYP1A2—Dasatinib—hematologic cancer	0.00636	0.0166	CbGbCtD
Rimonabant—CYP3A4—Methoxsalen—hematologic cancer	0.00596	0.0155	CbGbCtD
Rimonabant—CYP2D6—Nilotinib—hematologic cancer	0.00593	0.0155	CbGbCtD
Rimonabant—CYP2D6—Vinorelbine—hematologic cancer	0.00588	0.0153	CbGbCtD
Rimonabant—CYP3A4—Bortezomib—hematologic cancer	0.00567	0.0148	CbGbCtD
Rimonabant—CYP3A4—Daunorubicin—hematologic cancer	0.00542	0.0141	CbGbCtD
Rimonabant—CYP3A4—Cytarabine—hematologic cancer	0.00478	0.0125	CbGbCtD
Rimonabant—CYP3A4—Teniposide—hematologic cancer	0.00471	0.0123	CbGbCtD
Rimonabant—CYP3A4—Ifosfamide—hematologic cancer	0.00435	0.0113	CbGbCtD
Rimonabant—CNR2—hematopoietic system—hematologic cancer	0.00434	0.273	CbGeAlD
Rimonabant—CYP3A4—Imatinib—hematologic cancer	0.00415	0.0108	CbGbCtD
Rimonabant—CYP1A2—Etoposide—hematologic cancer	0.00396	0.0103	CbGbCtD
Rimonabant—CYP3A4—Ruxolitinib—hematologic cancer	0.00391	0.0102	CbGbCtD
Rimonabant—CYP3A4—Nilotinib—hematologic cancer	0.00377	0.00984	CbGbCtD
Rimonabant—CYP3A4—Vinorelbine—hematologic cancer	0.00374	0.00976	CbGbCtD
Rimonabant—CYP2C9—Cisplatin—hematologic cancer	0.00364	0.00948	CbGbCtD
Rimonabant—CYP2D6—Vinblastine—hematologic cancer	0.00363	0.00946	CbGbCtD
Rimonabant—CYP3A4—Triamcinolone—hematologic cancer	0.00342	0.00892	CbGbCtD
Rimonabant—CYP3A4—Dasatinib—hematologic cancer	0.00333	0.0087	CbGbCtD
Rimonabant—CYP3A4—Mitoxantrone—hematologic cancer	0.00329	0.00859	CbGbCtD
Rimonabant—CYP2C9—Dexamethasone—hematologic cancer	0.00294	0.00766	CbGbCtD
Rimonabant—CYP3A4—Betamethasone—hematologic cancer	0.00294	0.00766	CbGbCtD
Rimonabant—CYP3A4—Prednisolone—hematologic cancer	0.0029	0.00755	CbGbCtD
Rimonabant—CNR2—blood—hematologic cancer	0.00288	0.181	CbGeAlD
Rimonabant—CYP3A4—Prednisone—hematologic cancer	0.00274	0.00713	CbGbCtD
Rimonabant—CYP2D6—Dexamethasone—hematologic cancer	0.00269	0.007	CbGbCtD
Rimonabant—CYP3A4—Irinotecan—hematologic cancer	0.00259	0.00676	CbGbCtD
Rimonabant—CYP3A4—Vinblastine—hematologic cancer	0.00231	0.00601	CbGbCtD
Rimonabant—CYP3A4—Vincristine—hematologic cancer	0.00227	0.00591	CbGbCtD
Rimonabant—CYP2D6—Doxorubicin—hematologic cancer	0.00223	0.00581	CbGbCtD
Rimonabant—CYP3A4—Etoposide—hematologic cancer	0.00208	0.00542	CbGbCtD
Rimonabant—CNR1—lung—hematologic cancer	0.00176	0.11	CbGeAlD
Rimonabant—CYP3A4—Dexamethasone—hematologic cancer	0.00171	0.00445	CbGbCtD
Rimonabant—CNR1—testis—hematologic cancer	0.00166	0.104	CbGeAlD
Rimonabant—CYP3A4—Doxorubicin—hematologic cancer	0.00142	0.00369	CbGbCtD
Rimonabant—CNR1—lymph node—hematologic cancer	0.0012	0.0755	CbGeAlD
Rimonabant—CYP1A2—hematopoietic system—hematologic cancer	0.000617	0.0388	CbGeAlD
Rimonabant—CYP2C9—hematopoietic system—hematologic cancer	0.000586	0.0368	CbGeAlD
Rimonabant—CYP3A4—hematopoietic system—hematologic cancer	0.000447	0.0281	CbGeAlD
Rimonabant—CYP2D6—hematopoietic system—hematologic cancer	0.00044	0.0276	CbGeAlD
Rimonabant—CYP1A2—blood—hematologic cancer	0.000409	0.0257	CbGeAlD
Rimonabant—CYP2C9—blood—hematologic cancer	0.000388	0.0244	CbGeAlD
Rimonabant—CYP1A2—lung—hematologic cancer	0.000358	0.0225	CbGeAlD
Rimonabant—CYP3A4—blood—hematologic cancer	0.000296	0.0186	CbGeAlD
Rimonabant—CYP2D6—blood—hematologic cancer	0.000291	0.0183	CbGeAlD
Rimonabant—CYP2D6—testis—hematologic cancer	0.000241	0.0151	CbGeAlD
Rimonabant—Fatigue—Etoposide—hematologic cancer	4.26e-05	0.000318	CcSEcCtD
Rimonabant—Vomiting—Thalidomide—hematologic cancer	4.23e-05	0.000316	CcSEcCtD
Rimonabant—Anxiety—Dexamethasone—hematologic cancer	4.22e-05	0.000315	CcSEcCtD
Rimonabant—Anxiety—Betamethasone—hematologic cancer	4.22e-05	0.000315	CcSEcCtD
Rimonabant—Dizziness—Carmustine—hematologic cancer	4.22e-05	0.000315	CcSEcCtD
Rimonabant—Rash—Thalidomide—hematologic cancer	4.19e-05	0.000313	CcSEcCtD
Rimonabant—Dermatitis—Thalidomide—hematologic cancer	4.19e-05	0.000313	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Doxorubicin—hematologic cancer	4.18e-05	0.000313	CcSEcCtD
Rimonabant—Dizziness—Alitretinoin—hematologic cancer	4.18e-05	0.000312	CcSEcCtD
Rimonabant—Diarrhoea—Vincristine—hematologic cancer	4.17e-05	0.000311	CcSEcCtD
Rimonabant—Headache—Thalidomide—hematologic cancer	4.16e-05	0.000311	CcSEcCtD
Rimonabant—Asthenia—Gemcitabine—hematologic cancer	4.15e-05	0.00031	CcSEcCtD
Rimonabant—Dizziness—Ifosfamide—hematologic cancer	4.13e-05	0.000309	CcSEcCtD
Rimonabant—Pruritus—Gemcitabine—hematologic cancer	4.09e-05	0.000305	CcSEcCtD
Rimonabant—Nausea—Thiotepa—hematologic cancer	4.08e-05	0.000305	CcSEcCtD
Rimonabant—Sinusitis—Epirubicin—hematologic cancer	4.07e-05	0.000304	CcSEcCtD
Rimonabant—Diarrhoea—Mitoxantrone—hematologic cancer	4.06e-05	0.000303	CcSEcCtD
Rimonabant—Diarrhoea—Irinotecan—hematologic cancer	4.06e-05	0.000303	CcSEcCtD
Rimonabant—Vomiting—Carmustine—hematologic cancer	4.06e-05	0.000303	CcSEcCtD
Rimonabant—Insomnia—Triamcinolone—hematologic cancer	4.05e-05	0.000302	CcSEcCtD
Rimonabant—Gastrointestinal pain—Etoposide—hematologic cancer	4.04e-05	0.000301	CcSEcCtD
Rimonabant—Infection—Dexamethasone—hematologic cancer	4.04e-05	0.000301	CcSEcCtD
Rimonabant—Infection—Betamethasone—hematologic cancer	4.04e-05	0.000301	CcSEcCtD
Rimonabant—Dizziness—Vincristine—hematologic cancer	4.03e-05	0.000301	CcSEcCtD
Rimonabant—Rash—Carmustine—hematologic cancer	4.03e-05	0.000301	CcSEcCtD
Rimonabant—Dermatitis—Carmustine—hematologic cancer	4.02e-05	0.0003	CcSEcCtD
Rimonabant—Vomiting—Alitretinoin—hematologic cancer	4.02e-05	0.0003	CcSEcCtD
Rimonabant—Paraesthesia—Triamcinolone—hematologic cancer	4.02e-05	0.0003	CcSEcCtD
Rimonabant—Infestation NOS—Doxorubicin—hematologic cancer	4.01e-05	0.0003	CcSEcCtD
Rimonabant—Infestation—Doxorubicin—hematologic cancer	4.01e-05	0.0003	CcSEcCtD
Rimonabant—Headache—Carmustine—hematologic cancer	4e-05	0.000299	CcSEcCtD
Rimonabant—Rash—Alitretinoin—hematologic cancer	3.99e-05	0.000298	CcSEcCtD
Rimonabant—Nervous system disorder—Dexamethasone—hematologic cancer	3.98e-05	0.000298	CcSEcCtD
Rimonabant—Nervous system disorder—Betamethasone—hematologic cancer	3.98e-05	0.000298	CcSEcCtD
Rimonabant—Dermatitis—Alitretinoin—hematologic cancer	3.98e-05	0.000298	CcSEcCtD
Rimonabant—Vomiting—Ifosfamide—hematologic cancer	3.97e-05	0.000297	CcSEcCtD
Rimonabant—Headache—Alitretinoin—hematologic cancer	3.96e-05	0.000296	CcSEcCtD
Rimonabant—Diarrhoea—Gemcitabine—hematologic cancer	3.96e-05	0.000295	CcSEcCtD
Rimonabant—Nausea—Thalidomide—hematologic cancer	3.95e-05	0.000295	CcSEcCtD
Rimonabant—Rash—Ifosfamide—hematologic cancer	3.94e-05	0.000294	CcSEcCtD
Rimonabant—Dermatitis—Ifosfamide—hematologic cancer	3.94e-05	0.000294	CcSEcCtD
Rimonabant—Hyperhidrosis—Betamethasone—hematologic cancer	3.93e-05	0.000293	CcSEcCtD
Rimonabant—Hyperhidrosis—Dexamethasone—hematologic cancer	3.93e-05	0.000293	CcSEcCtD
Rimonabant—Dizziness—Irinotecan—hematologic cancer	3.92e-05	0.000293	CcSEcCtD
Rimonabant—Abdominal pain—Etoposide—hematologic cancer	3.9e-05	0.000291	CcSEcCtD
Rimonabant—Hypoaesthesia—Epirubicin—hematologic cancer	3.88e-05	0.000289	CcSEcCtD
Rimonabant—Vomiting—Vincristine—hematologic cancer	3.87e-05	0.000289	CcSEcCtD
Rimonabant—Anorexia—Betamethasone—hematologic cancer	3.87e-05	0.000289	CcSEcCtD
Rimonabant—Anorexia—Dexamethasone—hematologic cancer	3.87e-05	0.000289	CcSEcCtD
Rimonabant—Asthenia—Cisplatin—hematologic cancer	3.87e-05	0.000289	CcSEcCtD
Rimonabant—Fatigue—Triamcinolone—hematologic cancer	3.86e-05	0.000288	CcSEcCtD
Rimonabant—Rash—Vincristine—hematologic cancer	3.84e-05	0.000287	CcSEcCtD
Rimonabant—Dermatitis—Vincristine—hematologic cancer	3.84e-05	0.000287	CcSEcCtD
Rimonabant—Connective tissue disorder—Epirubicin—hematologic cancer	3.83e-05	0.000286	CcSEcCtD
Rimonabant—Headache—Vincristine—hematologic cancer	3.82e-05	0.000285	CcSEcCtD
Rimonabant—Nausea—Carmustine—hematologic cancer	3.79e-05	0.000283	CcSEcCtD
Rimonabant—Angiopathy—Methotrexate—hematologic cancer	3.78e-05	0.000282	CcSEcCtD
Rimonabant—Vomiting—Irinotecan—hematologic cancer	3.77e-05	0.000282	CcSEcCtD
Rimonabant—Vomiting—Mitoxantrone—hematologic cancer	3.77e-05	0.000282	CcSEcCtD
Rimonabant—Sinusitis—Doxorubicin—hematologic cancer	3.77e-05	0.000281	CcSEcCtD
Rimonabant—Nausea—Alitretinoin—hematologic cancer	3.76e-05	0.000281	CcSEcCtD
Rimonabant—Convulsion—Prednisone—hematologic cancer	3.76e-05	0.000281	CcSEcCtD
Rimonabant—Mediastinal disorder—Methotrexate—hematologic cancer	3.75e-05	0.00028	CcSEcCtD
Rimonabant—Rash—Mitoxantrone—hematologic cancer	3.74e-05	0.000279	CcSEcCtD
Rimonabant—Rash—Irinotecan—hematologic cancer	3.74e-05	0.000279	CcSEcCtD
Rimonabant—Dermatitis—Irinotecan—hematologic cancer	3.74e-05	0.000279	CcSEcCtD
Rimonabant—Dermatitis—Mitoxantrone—hematologic cancer	3.74e-05	0.000279	CcSEcCtD
Rimonabant—Headache—Mitoxantrone—hematologic cancer	3.72e-05	0.000278	CcSEcCtD
Rimonabant—Headache—Irinotecan—hematologic cancer	3.72e-05	0.000278	CcSEcCtD
Rimonabant—Nausea—Ifosfamide—hematologic cancer	3.71e-05	0.000277	CcSEcCtD
Rimonabant—Diarrhoea—Cisplatin—hematologic cancer	3.69e-05	0.000275	CcSEcCtD
Rimonabant—Anxiety—Prednisone—hematologic cancer	3.68e-05	0.000275	CcSEcCtD
Rimonabant—Vomiting—Gemcitabine—hematologic cancer	3.68e-05	0.000275	CcSEcCtD
Rimonabant—Insomnia—Betamethasone—hematologic cancer	3.67e-05	0.000274	CcSEcCtD
Rimonabant—Insomnia—Dexamethasone—hematologic cancer	3.67e-05	0.000274	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	3.67e-05	0.000274	CcSEcCtD
Rimonabant—Paraesthesia—Dexamethasone—hematologic cancer	3.65e-05	0.000272	CcSEcCtD
Rimonabant—Paraesthesia—Betamethasone—hematologic cancer	3.65e-05	0.000272	CcSEcCtD
Rimonabant—Mental disorder—Methotrexate—hematologic cancer	3.65e-05	0.000272	CcSEcCtD
Rimonabant—Rash—Gemcitabine—hematologic cancer	3.65e-05	0.000272	CcSEcCtD
Rimonabant—Dermatitis—Gemcitabine—hematologic cancer	3.64e-05	0.000272	CcSEcCtD
Rimonabant—Malnutrition—Methotrexate—hematologic cancer	3.62e-05	0.000271	CcSEcCtD
Rimonabant—Headache—Gemcitabine—hematologic cancer	3.62e-05	0.00027	CcSEcCtD
Rimonabant—Nausea—Vincristine—hematologic cancer	3.62e-05	0.00027	CcSEcCtD
Rimonabant—Hypoaesthesia—Doxorubicin—hematologic cancer	3.59e-05	0.000268	CcSEcCtD
Rimonabant—Asthenia—Etoposide—hematologic cancer	3.54e-05	0.000265	CcSEcCtD
Rimonabant—Connective tissue disorder—Doxorubicin—hematologic cancer	3.54e-05	0.000264	CcSEcCtD
Rimonabant—Angiopathy—Epirubicin—hematologic cancer	3.53e-05	0.000264	CcSEcCtD
Rimonabant—Decreased appetite—Betamethasone—hematologic cancer	3.53e-05	0.000264	CcSEcCtD
Rimonabant—Decreased appetite—Dexamethasone—hematologic cancer	3.53e-05	0.000264	CcSEcCtD
Rimonabant—Nausea—Irinotecan—hematologic cancer	3.53e-05	0.000263	CcSEcCtD
Rimonabant—Nausea—Mitoxantrone—hematologic cancer	3.53e-05	0.000263	CcSEcCtD
Rimonabant—Infection—Prednisone—hematologic cancer	3.51e-05	0.000263	CcSEcCtD
Rimonabant—Mediastinal disorder—Epirubicin—hematologic cancer	3.51e-05	0.000262	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.51e-05	0.000262	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.51e-05	0.000262	CcSEcCtD
Rimonabant—Fatigue—Betamethasone—hematologic cancer	3.5e-05	0.000262	CcSEcCtD
Rimonabant—Fatigue—Dexamethasone—hematologic cancer	3.5e-05	0.000262	CcSEcCtD
Rimonabant—Pruritus—Etoposide—hematologic cancer	3.49e-05	0.000261	CcSEcCtD
Rimonabant—Nervous system disorder—Prednisone—hematologic cancer	3.47e-05	0.000259	CcSEcCtD
Rimonabant—Skin disorder—Prednisone—hematologic cancer	3.44e-05	0.000257	CcSEcCtD
Rimonabant—Nausea—Gemcitabine—hematologic cancer	3.43e-05	0.000256	CcSEcCtD
Rimonabant—Vomiting—Cisplatin—hematologic cancer	3.43e-05	0.000256	CcSEcCtD
Rimonabant—Hyperhidrosis—Prednisone—hematologic cancer	3.42e-05	0.000255	CcSEcCtD
Rimonabant—Mental disorder—Epirubicin—hematologic cancer	3.41e-05	0.000255	CcSEcCtD
Rimonabant—Rash—Cisplatin—hematologic cancer	3.4e-05	0.000254	CcSEcCtD
Rimonabant—Dermatitis—Cisplatin—hematologic cancer	3.39e-05	0.000253	CcSEcCtD
Rimonabant—Malnutrition—Epirubicin—hematologic cancer	3.39e-05	0.000253	CcSEcCtD
Rimonabant—Diarrhoea—Etoposide—hematologic cancer	3.38e-05	0.000252	CcSEcCtD
Rimonabant—Anorexia—Prednisone—hematologic cancer	3.37e-05	0.000252	CcSEcCtD
Rimonabant—Tension—Epirubicin—hematologic cancer	3.33e-05	0.000248	CcSEcCtD
Rimonabant—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.32e-05	0.000248	CcSEcCtD
Rimonabant—Gastrointestinal pain—Betamethasone—hematologic cancer	3.32e-05	0.000248	CcSEcCtD
Rimonabant—Nervousness—Epirubicin—hematologic cancer	3.29e-05	0.000246	CcSEcCtD
Rimonabant—Angiopathy—Doxorubicin—hematologic cancer	3.27e-05	0.000244	CcSEcCtD
Rimonabant—Dizziness—Etoposide—hematologic cancer	3.26e-05	0.000244	CcSEcCtD
Rimonabant—Muscle spasms—Epirubicin—hematologic cancer	3.26e-05	0.000243	CcSEcCtD
Rimonabant—Mediastinal disorder—Doxorubicin—hematologic cancer	3.25e-05	0.000243	CcSEcCtD
Rimonabant—Dizziness—Prednisolone—hematologic cancer	3.22e-05	0.00024	CcSEcCtD
Rimonabant—Asthenia—Triamcinolone—hematologic cancer	3.21e-05	0.00024	CcSEcCtD
Rimonabant—Abdominal pain—Betamethasone—hematologic cancer	3.21e-05	0.00024	CcSEcCtD
Rimonabant—Abdominal pain—Dexamethasone—hematologic cancer	3.21e-05	0.00024	CcSEcCtD
Rimonabant—Nausea—Cisplatin—hematologic cancer	3.2e-05	0.000239	CcSEcCtD
Rimonabant—Insomnia—Prednisone—hematologic cancer	3.2e-05	0.000239	CcSEcCtD
Rimonabant—Paraesthesia—Prednisone—hematologic cancer	3.18e-05	0.000237	CcSEcCtD
Rimonabant—Pruritus—Triamcinolone—hematologic cancer	3.17e-05	0.000237	CcSEcCtD
Rimonabant—Mental disorder—Doxorubicin—hematologic cancer	3.16e-05	0.000236	CcSEcCtD
Rimonabant—Convulsion—Methotrexate—hematologic cancer	3.14e-05	0.000234	CcSEcCtD
Rimonabant—Vomiting—Etoposide—hematologic cancer	3.14e-05	0.000234	CcSEcCtD
Rimonabant—Malnutrition—Doxorubicin—hematologic cancer	3.14e-05	0.000234	CcSEcCtD
Rimonabant—Rash—Etoposide—hematologic cancer	3.11e-05	0.000232	CcSEcCtD
Rimonabant—Dermatitis—Etoposide—hematologic cancer	3.11e-05	0.000232	CcSEcCtD
Rimonabant—Headache—Etoposide—hematologic cancer	3.09e-05	0.000231	CcSEcCtD
Rimonabant—Tension—Doxorubicin—hematologic cancer	3.08e-05	0.00023	CcSEcCtD
Rimonabant—Decreased appetite—Prednisone—hematologic cancer	3.08e-05	0.00023	CcSEcCtD
Rimonabant—Rash—Prednisolone—hematologic cancer	3.07e-05	0.000229	CcSEcCtD
Rimonabant—Dermatitis—Prednisolone—hematologic cancer	3.07e-05	0.000229	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.06e-05	0.000229	CcSEcCtD
Rimonabant—Fatigue—Prednisone—hematologic cancer	3.05e-05	0.000228	CcSEcCtD
Rimonabant—Headache—Prednisolone—hematologic cancer	3.05e-05	0.000228	CcSEcCtD
Rimonabant—Nervousness—Doxorubicin—hematologic cancer	3.05e-05	0.000228	CcSEcCtD
Rimonabant—Muscle spasms—Doxorubicin—hematologic cancer	3.02e-05	0.000225	CcSEcCtD
Rimonabant—Dizziness—Triamcinolone—hematologic cancer	2.96e-05	0.000221	CcSEcCtD
Rimonabant—Convulsion—Epirubicin—hematologic cancer	2.94e-05	0.000219	CcSEcCtD
Rimonabant—Infection—Methotrexate—hematologic cancer	2.94e-05	0.000219	CcSEcCtD
Rimonabant—Nausea—Etoposide—hematologic cancer	2.93e-05	0.000219	CcSEcCtD
Rimonabant—Asthenia—Dexamethasone—hematologic cancer	2.91e-05	0.000218	CcSEcCtD
Rimonabant—Asthenia—Betamethasone—hematologic cancer	2.91e-05	0.000218	CcSEcCtD
Rimonabant—Nervous system disorder—Methotrexate—hematologic cancer	2.9e-05	0.000217	CcSEcCtD
Rimonabant—Gastrointestinal pain—Prednisone—hematologic cancer	2.89e-05	0.000216	CcSEcCtD
Rimonabant—Nausea—Prednisolone—hematologic cancer	2.89e-05	0.000216	CcSEcCtD
Rimonabant—Anxiety—Epirubicin—hematologic cancer	2.88e-05	0.000215	CcSEcCtD
Rimonabant—Pruritus—Dexamethasone—hematologic cancer	2.87e-05	0.000215	CcSEcCtD
Rimonabant—Pruritus—Betamethasone—hematologic cancer	2.87e-05	0.000215	CcSEcCtD
Rimonabant—Skin disorder—Methotrexate—hematologic cancer	2.87e-05	0.000214	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.87e-05	0.000214	CcSEcCtD
Rimonabant—Hyperhidrosis—Methotrexate—hematologic cancer	2.86e-05	0.000213	CcSEcCtD
Rimonabant—Vomiting—Triamcinolone—hematologic cancer	2.85e-05	0.000213	CcSEcCtD
Rimonabant—Rash—Triamcinolone—hematologic cancer	2.82e-05	0.000211	CcSEcCtD
Rimonabant—Dry mouth—Epirubicin—hematologic cancer	2.82e-05	0.000211	CcSEcCtD
Rimonabant—Dermatitis—Triamcinolone—hematologic cancer	2.82e-05	0.000211	CcSEcCtD
Rimonabant—Anorexia—Methotrexate—hematologic cancer	2.82e-05	0.00021	CcSEcCtD
Rimonabant—Headache—Triamcinolone—hematologic cancer	2.8e-05	0.000209	CcSEcCtD
Rimonabant—Abdominal pain—Prednisone—hematologic cancer	2.8e-05	0.000209	CcSEcCtD
Rimonabant—Diarrhoea—Betamethasone—hematologic cancer	2.78e-05	0.000208	CcSEcCtD
Rimonabant—Diarrhoea—Dexamethasone—hematologic cancer	2.78e-05	0.000208	CcSEcCtD
Rimonabant—Infection—Epirubicin—hematologic cancer	2.75e-05	0.000205	CcSEcCtD
Rimonabant—Convulsion—Doxorubicin—hematologic cancer	2.72e-05	0.000203	CcSEcCtD
Rimonabant—Nervous system disorder—Epirubicin—hematologic cancer	2.71e-05	0.000203	CcSEcCtD
Rimonabant—Skin disorder—Epirubicin—hematologic cancer	2.69e-05	0.000201	CcSEcCtD
Rimonabant—Dizziness—Betamethasone—hematologic cancer	2.69e-05	0.000201	CcSEcCtD
Rimonabant—Dizziness—Dexamethasone—hematologic cancer	2.69e-05	0.000201	CcSEcCtD
Rimonabant—Hyperhidrosis—Epirubicin—hematologic cancer	2.68e-05	0.0002	CcSEcCtD
Rimonabant—Insomnia—Methotrexate—hematologic cancer	2.67e-05	0.0002	CcSEcCtD
Rimonabant—Anxiety—Doxorubicin—hematologic cancer	2.66e-05	0.000199	CcSEcCtD
Rimonabant—Nausea—Triamcinolone—hematologic cancer	2.66e-05	0.000199	CcSEcCtD
Rimonabant—Paraesthesia—Methotrexate—hematologic cancer	2.66e-05	0.000198	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.65e-05	0.000198	CcSEcCtD
Rimonabant—Anorexia—Epirubicin—hematologic cancer	2.64e-05	0.000197	CcSEcCtD
Rimonabant—Dry mouth—Doxorubicin—hematologic cancer	2.61e-05	0.000195	CcSEcCtD
Rimonabant—Vomiting—Dexamethasone—hematologic cancer	2.58e-05	0.000193	CcSEcCtD
Rimonabant—Vomiting—Betamethasone—hematologic cancer	2.58e-05	0.000193	CcSEcCtD
Rimonabant—Decreased appetite—Methotrexate—hematologic cancer	2.57e-05	0.000192	CcSEcCtD
Rimonabant—Rash—Betamethasone—hematologic cancer	2.56e-05	0.000191	CcSEcCtD
Rimonabant—Rash—Dexamethasone—hematologic cancer	2.56e-05	0.000191	CcSEcCtD
Rimonabant—Dermatitis—Betamethasone—hematologic cancer	2.56e-05	0.000191	CcSEcCtD
Rimonabant—Dermatitis—Dexamethasone—hematologic cancer	2.56e-05	0.000191	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.55e-05	0.000191	CcSEcCtD
Rimonabant—Fatigue—Methotrexate—hematologic cancer	2.55e-05	0.00019	CcSEcCtD
Rimonabant—Headache—Betamethasone—hematologic cancer	2.55e-05	0.00019	CcSEcCtD
Rimonabant—Headache—Dexamethasone—hematologic cancer	2.55e-05	0.00019	CcSEcCtD
Rimonabant—Infection—Doxorubicin—hematologic cancer	2.54e-05	0.00019	CcSEcCtD
Rimonabant—Asthenia—Prednisone—hematologic cancer	2.54e-05	0.00019	CcSEcCtD
Rimonabant—Nervous system disorder—Doxorubicin—hematologic cancer	2.51e-05	0.000188	CcSEcCtD
Rimonabant—Pruritus—Prednisone—hematologic cancer	2.5e-05	0.000187	CcSEcCtD
Rimonabant—Insomnia—Epirubicin—hematologic cancer	2.5e-05	0.000187	CcSEcCtD
Rimonabant—Skin disorder—Doxorubicin—hematologic cancer	2.49e-05	0.000186	CcSEcCtD
Rimonabant—Paraesthesia—Epirubicin—hematologic cancer	2.48e-05	0.000186	CcSEcCtD
Rimonabant—Hyperhidrosis—Doxorubicin—hematologic cancer	2.48e-05	0.000185	CcSEcCtD
Rimonabant—Anorexia—Doxorubicin—hematologic cancer	2.44e-05	0.000182	CcSEcCtD
Rimonabant—Diarrhoea—Prednisone—hematologic cancer	2.42e-05	0.000181	CcSEcCtD
Rimonabant—Gastrointestinal pain—Methotrexate—hematologic cancer	2.42e-05	0.000181	CcSEcCtD
Rimonabant—Nausea—Dexamethasone—hematologic cancer	2.41e-05	0.00018	CcSEcCtD
Rimonabant—Nausea—Betamethasone—hematologic cancer	2.41e-05	0.00018	CcSEcCtD
Rimonabant—Decreased appetite—Epirubicin—hematologic cancer	2.41e-05	0.00018	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.39e-05	0.000178	CcSEcCtD
Rimonabant—Fatigue—Epirubicin—hematologic cancer	2.39e-05	0.000178	CcSEcCtD
Rimonabant—Dizziness—Prednisone—hematologic cancer	2.34e-05	0.000175	CcSEcCtD
Rimonabant—Abdominal pain—Methotrexate—hematologic cancer	2.34e-05	0.000175	CcSEcCtD
Rimonabant—Insomnia—Doxorubicin—hematologic cancer	2.32e-05	0.000173	CcSEcCtD
Rimonabant—Paraesthesia—Doxorubicin—hematologic cancer	2.3e-05	0.000172	CcSEcCtD
Rimonabant—Gastrointestinal pain—Epirubicin—hematologic cancer	2.26e-05	0.000169	CcSEcCtD
Rimonabant—Vomiting—Prednisone—hematologic cancer	2.25e-05	0.000168	CcSEcCtD
Rimonabant—Rash—Prednisone—hematologic cancer	2.23e-05	0.000167	CcSEcCtD
Rimonabant—Dermatitis—Prednisone—hematologic cancer	2.23e-05	0.000166	CcSEcCtD
Rimonabant—Decreased appetite—Doxorubicin—hematologic cancer	2.23e-05	0.000166	CcSEcCtD
Rimonabant—Headache—Prednisone—hematologic cancer	2.22e-05	0.000166	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.21e-05	0.000165	CcSEcCtD
Rimonabant—Fatigue—Doxorubicin—hematologic cancer	2.21e-05	0.000165	CcSEcCtD
Rimonabant—Abdominal pain—Epirubicin—hematologic cancer	2.19e-05	0.000163	CcSEcCtD
Rimonabant—Asthenia—Methotrexate—hematologic cancer	2.12e-05	0.000158	CcSEcCtD
Rimonabant—Nausea—Prednisone—hematologic cancer	2.1e-05	0.000157	CcSEcCtD
Rimonabant—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.09e-05	0.000156	CcSEcCtD
Rimonabant—Pruritus—Methotrexate—hematologic cancer	2.09e-05	0.000156	CcSEcCtD
Rimonabant—Abdominal pain—Doxorubicin—hematologic cancer	2.02e-05	0.000151	CcSEcCtD
Rimonabant—Diarrhoea—Methotrexate—hematologic cancer	2.02e-05	0.000151	CcSEcCtD
Rimonabant—Asthenia—Epirubicin—hematologic cancer	1.99e-05	0.000148	CcSEcCtD
Rimonabant—Pruritus—Epirubicin—hematologic cancer	1.96e-05	0.000146	CcSEcCtD
Rimonabant—Dizziness—Methotrexate—hematologic cancer	1.96e-05	0.000146	CcSEcCtD
Rimonabant—Diarrhoea—Epirubicin—hematologic cancer	1.89e-05	0.000141	CcSEcCtD
Rimonabant—Vomiting—Methotrexate—hematologic cancer	1.88e-05	0.00014	CcSEcCtD
Rimonabant—Rash—Methotrexate—hematologic cancer	1.86e-05	0.000139	CcSEcCtD
Rimonabant—Dermatitis—Methotrexate—hematologic cancer	1.86e-05	0.000139	CcSEcCtD
Rimonabant—Headache—Methotrexate—hematologic cancer	1.85e-05	0.000138	CcSEcCtD
Rimonabant—Asthenia—Doxorubicin—hematologic cancer	1.84e-05	0.000137	CcSEcCtD
Rimonabant—Dizziness—Epirubicin—hematologic cancer	1.83e-05	0.000137	CcSEcCtD
Rimonabant—Pruritus—Doxorubicin—hematologic cancer	1.81e-05	0.000135	CcSEcCtD
Rimonabant—Vomiting—Epirubicin—hematologic cancer	1.76e-05	0.000131	CcSEcCtD
Rimonabant—Nausea—Methotrexate—hematologic cancer	1.76e-05	0.000131	CcSEcCtD
Rimonabant—Diarrhoea—Doxorubicin—hematologic cancer	1.75e-05	0.000131	CcSEcCtD
Rimonabant—Rash—Epirubicin—hematologic cancer	1.74e-05	0.00013	CcSEcCtD
Rimonabant—Dermatitis—Epirubicin—hematologic cancer	1.74e-05	0.00013	CcSEcCtD
Rimonabant—Headache—Epirubicin—hematologic cancer	1.73e-05	0.000129	CcSEcCtD
Rimonabant—Dizziness—Doxorubicin—hematologic cancer	1.69e-05	0.000126	CcSEcCtD
Rimonabant—Nausea—Epirubicin—hematologic cancer	1.64e-05	0.000123	CcSEcCtD
Rimonabant—Vomiting—Doxorubicin—hematologic cancer	1.63e-05	0.000122	CcSEcCtD
Rimonabant—Rash—Doxorubicin—hematologic cancer	1.61e-05	0.000121	CcSEcCtD
Rimonabant—Dermatitis—Doxorubicin—hematologic cancer	1.61e-05	0.00012	CcSEcCtD
Rimonabant—Headache—Doxorubicin—hematologic cancer	1.6e-05	0.00012	CcSEcCtD
Rimonabant—Nausea—Doxorubicin—hematologic cancer	1.52e-05	0.000114	CcSEcCtD
Rimonabant—CYP1A2—Metabolism—CDA—hematologic cancer	8.37e-06	0.000171	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—MTAP—hematologic cancer	8.33e-06	0.00017	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—HRAS—hematologic cancer	8.15e-06	0.000167	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PC—hematologic cancer	8.06e-06	0.000165	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MAPK3—hematologic cancer	8.03e-06	0.000164	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CDKN1B—hematologic cancer	8.01e-06	0.000164	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—AKT1—hematologic cancer	7.92e-06	0.000162	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CASP3—hematologic cancer	7.85e-06	0.000161	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL2—hematologic cancer	7.84e-06	0.00016	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MYC—hematologic cancer	7.81e-06	0.00016	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—IL6—hematologic cancer	7.8e-06	0.00016	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TGFB1—hematologic cancer	7.79e-06	0.000159	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GBA—hematologic cancer	7.78e-06	0.000159	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC35B2—hematologic cancer	7.78e-06	0.000159	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCND1—hematologic cancer	7.64e-06	0.000156	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—JUN—hematologic cancer	7.63e-06	0.000156	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—FHL2—hematologic cancer	7.49e-06	0.000153	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—B3GAT1—hematologic cancer	7.45e-06	0.000152	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—DCK—hematologic cancer	7.45e-06	0.000152	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ASNS—hematologic cancer	7.45e-06	0.000152	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—FHL2—hematologic cancer	7.43e-06	0.000152	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CDKN1A—hematologic cancer	7.39e-06	0.000151	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PTEN—hematologic cancer	7.38e-06	0.000151	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—AGRN—hematologic cancer	7.35e-06	0.00015	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—AGRN—hematologic cancer	7.28e-06	0.000149	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—KRAS—hematologic cancer	7.22e-06	0.000148	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MAPK8—hematologic cancer	7.21e-06	0.000148	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—AKT1—hematologic cancer	7.2e-06	0.000147	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—MTAP—hematologic cancer	7.12e-06	0.000146	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HDC—hematologic cancer	7.06e-06	0.000145	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—EP300—hematologic cancer	7.03e-06	0.000144	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—IDH2—hematologic cancer	6.96e-06	0.000142	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—HMMR—hematologic cancer	6.96e-06	0.000142	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—IDH2—hematologic cancer	6.9e-06	0.000141	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—HMMR—hematologic cancer	6.9e-06	0.000141	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—SRC—hematologic cancer	6.84e-06	0.00014	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—VEGFA—hematologic cancer	6.66e-06	0.000136	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PIK3CA—hematologic cancer	6.63e-06	0.000136	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—STAT3—hematologic cancer	6.6e-06	0.000135	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NRAS—hematologic cancer	6.58e-06	0.000135	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ARNTL—hematologic cancer	6.55e-06	0.000134	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	6.51e-06	0.000133	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ARNTL—hematologic cancer	6.49e-06	0.000133	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CDA—hematologic cancer	6.46e-06	0.000132	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TP53—hematologic cancer	6.41e-06	0.000131	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CA9—hematologic cancer	6.37e-06	0.00013	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ACP5—hematologic cancer	6.37e-06	0.00013	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—FHL2—hematologic cancer	6.35e-06	0.00013	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ACP5—hematologic cancer	6.31e-06	0.000129	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CA9—hematologic cancer	6.31e-06	0.000129	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MAPK3—hematologic cancer	6.3e-06	0.000129	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NCOR2—hematologic cancer	6.29e-06	0.000129	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NCOR2—hematologic cancer	6.23e-06	0.000127	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—AGRN—hematologic cancer	6.22e-06	0.000127	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PC—hematologic cancer	6.22e-06	0.000127	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—HRAS—hematologic cancer	6.13e-06	0.000125	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MYC—hematologic cancer	6.13e-06	0.000125	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TGFB1—hematologic cancer	6.11e-06	0.000125	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GBA—hematologic cancer	6.01e-06	0.000123	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC35B2—hematologic cancer	6.01e-06	0.000123	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—IDH1—hematologic cancer	5.99e-06	0.000122	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—IDH1—hematologic cancer	5.94e-06	0.000121	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ABCC3—hematologic cancer	5.92e-06	0.000121	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—TXN—hematologic cancer	5.92e-06	0.000121	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTO1—hematologic cancer	5.92e-06	0.000121	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—IDH2—hematologic cancer	5.9e-06	0.000121	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HMMR—hematologic cancer	5.9e-06	0.000121	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IL6—hematologic cancer	5.87e-06	0.00012	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—TXN—hematologic cancer	5.87e-06	0.00012	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ABCC3—hematologic cancer	5.87e-06	0.00012	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTO1—hematologic cancer	5.87e-06	0.00012	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SPHK1—hematologic cancer	5.79e-06	0.000119	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SPHK1—hematologic cancer	5.74e-06	0.000117	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—KRAS—hematologic cancer	5.66e-06	0.000116	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—UGT1A1—hematologic cancer	5.57e-06	0.000114	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	5.56e-06	0.000114	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ARNTL—hematologic cancer	5.55e-06	0.000113	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—UGT1A1—hematologic cancer	5.52e-06	0.000113	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—MTAP—hematologic cancer	5.49e-06	0.000112	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—AKT1—hematologic cancer	5.42e-06	0.000111	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SLC22A1—hematologic cancer	5.42e-06	0.000111	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CRABP1—hematologic cancer	5.42e-06	0.000111	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CA9—hematologic cancer	5.4e-06	0.00011	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ACP5—hematologic cancer	5.4e-06	0.00011	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SLC22A1—hematologic cancer	5.37e-06	0.00011	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CRABP1—hematologic cancer	5.37e-06	0.00011	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NCOR2—hematologic cancer	5.32e-06	0.000109	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ALOX5—hematologic cancer	5.28e-06	0.000108	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ALOX5—hematologic cancer	5.23e-06	0.000107	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PIK3CA—hematologic cancer	5.2e-06	0.000106	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NUP98—hematologic cancer	5.11e-06	0.000105	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—IDH1—hematologic cancer	5.07e-06	0.000104	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NUP98—hematologic cancer	5.07e-06	0.000104	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TP53—hematologic cancer	5.03e-06	0.000103	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—TXN—hematologic cancer	5.02e-06	0.000103	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ABCC3—hematologic cancer	5.02e-06	0.000103	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTO1—hematologic cancer	5.02e-06	0.000103	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ADCY7—hematologic cancer	4.96e-06	0.000101	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NCOA3—hematologic cancer	4.96e-06	0.000101	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NUP214—hematologic cancer	4.93e-06	0.000101	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ADCY7—hematologic cancer	4.92e-06	0.000101	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NCOA3—hematologic cancer	4.92e-06	0.000101	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SPHK1—hematologic cancer	4.91e-06	0.0001	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—FHL2—hematologic cancer	4.9e-06	0.0001	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NUP214—hematologic cancer	4.88e-06	9.99e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.83e-06	9.89e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—MTR—hematologic cancer	4.83e-06	9.87e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ABCG2—hematologic cancer	4.83e-06	9.87e-05	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HRAS—hematologic cancer	4.81e-06	9.85e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—AGRN—hematologic cancer	4.8e-06	9.82e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—MTR—hematologic cancer	4.78e-06	9.79e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ABCG2—hematologic cancer	4.78e-06	9.79e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ENO2—hematologic cancer	4.73e-06	9.68e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—UGT1A1—hematologic cancer	4.72e-06	9.65e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ENO2—hematologic cancer	4.69e-06	9.6e-05	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL6—hematologic cancer	4.61e-06	9.42e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTT1—hematologic cancer	4.59e-06	9.39e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC22A1—hematologic cancer	4.59e-06	9.38e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CRABP1—hematologic cancer	4.59e-06	9.38e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—IDH2—hematologic cancer	4.55e-06	9.31e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HMMR—hematologic cancer	4.55e-06	9.31e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTT1—hematologic cancer	4.55e-06	9.31e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SDC1—hematologic cancer	4.49e-06	9.18e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.48e-06	9.17e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ALOX5—hematologic cancer	4.47e-06	9.14e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SDC1—hematologic cancer	4.45e-06	9.1e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NUP98—hematologic cancer	4.33e-06	8.86e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.28e-06	8.76e-05	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—AKT1—hematologic cancer	4.25e-06	8.69e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.25e-06	8.69e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ADCY7—hematologic cancer	4.2e-06	8.6e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NCOA3—hematologic cancer	4.2e-06	8.6e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.19e-06	8.58e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NUP214—hematologic cancer	4.17e-06	8.54e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CA9—hematologic cancer	4.16e-06	8.52e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ACP5—hematologic cancer	4.16e-06	8.52e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.13e-06	8.45e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.11e-06	8.41e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ABCG2—hematologic cancer	4.09e-06	8.36e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—MTR—hematologic cancer	4.09e-06	8.36e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.01e-06	8.21e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ENO2—hematologic cancer	4.01e-06	8.2e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—IDH1—hematologic cancer	3.91e-06	8.01e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.89e-06	7.96e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.87e-06	7.92e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.87e-06	7.92e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—TXN—hematologic cancer	3.87e-06	7.92e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.83e-06	7.83e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NQO1—hematologic cancer	3.82e-06	7.8e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CD44—hematologic cancer	3.82e-06	7.8e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SDC1—hematologic cancer	3.8e-06	7.78e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.79e-06	7.75e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CD44—hematologic cancer	3.78e-06	7.74e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NQO1—hematologic cancer	3.78e-06	7.74e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.7e-06	7.58e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.64e-06	7.44e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.63e-06	7.43e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYCS—hematologic cancer	3.61e-06	7.38e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.59e-06	7.34e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.58e-06	7.33e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYCS—hematologic cancer	3.58e-06	7.32e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.56e-06	7.27e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.54e-06	7.24e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.54e-06	7.24e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.45e-06	7.06e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.43e-06	7.01e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NUP98—hematologic cancer	3.34e-06	6.83e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.24e-06	6.64e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.24e-06	6.64e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NQO1—hematologic cancer	3.23e-06	6.61e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CD44—hematologic cancer	3.23e-06	6.61e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NUP214—hematologic cancer	3.22e-06	6.59e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.2e-06	6.55e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTP1—hematologic cancer	3.18e-06	6.51e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.16e-06	6.47e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.16e-06	6.45e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—MTR—hematologic cancer	3.16e-06	6.45e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.15e-06	6.45e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ENO2—hematologic cancer	3.09e-06	6.33e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYCS—hematologic cancer	3.06e-06	6.26e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.05e-06	6.24e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.04e-06	6.22e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.01e-06	6.16e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTT1—hematologic cancer	3e-06	6.14e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.99e-06	6.11e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SDC1—hematologic cancer	2.93e-06	6e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.92e-06	5.98e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.92e-06	5.98e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.9e-06	5.93e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.9e-06	5.93e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.73e-06	5.59e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.7e-06	5.51e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.61e-06	5.33e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.58e-06	5.29e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.56e-06	5.24e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.55e-06	5.22e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CD44—hematologic cancer	2.49e-06	5.1e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NQO1—hematologic cancer	2.49e-06	5.1e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.48e-06	5.07e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.48e-06	5.07e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYCS—hematologic cancer	2.36e-06	4.83e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.35e-06	4.8e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.26e-06	4.62e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.19e-06	4.48e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.17e-06	4.44e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.15e-06	4.4e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.08e-06	4.26e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.01e-06	4.12e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CREBBP—hematologic cancer	2e-06	4.08e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.97e-06	4.03e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.93e-06	3.95e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.91e-06	3.91e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.91e-06	3.91e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.91e-06	3.9e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.89e-06	3.87e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ALB—hematologic cancer	1.88e-06	3.85e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ALB—hematologic cancer	1.87e-06	3.82e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.84e-06	3.76e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.8e-06	3.69e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.79e-06	3.65e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.71e-06	3.49e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.69e-06	3.46e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.66e-06	3.4e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.65e-06	3.37e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.62e-06	3.31e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ALB—hematologic cancer	1.6e-06	3.27e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.53e-06	3.12e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTEN—hematologic cancer	1.44e-06	2.94e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTEN—hematologic cancer	1.43e-06	2.92e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.42e-06	2.9e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.41e-06	2.88e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—EP300—hematologic cancer	1.37e-06	2.8e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—EP300—hematologic cancer	1.36e-06	2.78e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.32e-06	2.69e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.25e-06	2.55e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ALB—hematologic cancer	1.23e-06	2.52e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTEN—hematologic cancer	1.22e-06	2.49e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.18e-06	2.41e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—EP300—hematologic cancer	1.16e-06	2.38e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.09e-06	2.23e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.01e-06	2.07e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.01e-06	2.06e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTEN—hematologic cancer	9.4e-07	1.92e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—EP300—hematologic cancer	8.96e-07	1.83e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CA—hematologic cancer	8.59e-07	1.76e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—AKT1—hematologic cancer	8.29e-07	1.69e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—AKT1—hematologic cancer	8.21e-07	1.68e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—AKT1—hematologic cancer	7.02e-07	1.44e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.63e-07	1.36e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—AKT1—hematologic cancer	5.42e-07	1.11e-05	CbGpPWpGaD
